{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:04:05Z","timestamp":1787069045469,"version":"build-2736575974"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.radonc.2025.111351","type":"journal-article","created":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T00:05:01Z","timestamp":1766189101000},"page":"111351","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Are the CTV-to-PTV margins currently used in online adaptive radiotherapy for prostate cancer too large? The impact of the distribution of microscopic disease on treatment margin requirements"],"prefix":"10.1016","volume":"216","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1632-9623","authenticated-orcid":false,"given":"Mathijs G.","family":"Dassen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"van Herk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5877-6790","authenticated-orcid":false,"given":"Marnix G.","family":"Witte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2807-8670","authenticated-orcid":false,"given":"Tomas","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0903-4149","authenticated-orcid":false,"given":"Floris","family":"Pos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uulke A.","family":"van der Heide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2025.111351_b0005","doi-asserted-by":"crossref","unstructured":"ICRU report 50: Prescribing, recording and reporting photon beam therapy. Journal of the ICRU, 1993. Os-26. https:\/\/doi.org\/10.1093\/jicru_os26.1.v.","DOI":"10.1093\/jicru_os26.1.v"},{"key":"10.1016\/j.radonc.2025.111351_b0010","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0360-3016(00)00518-6","article-title":"The probability of correct target dosage: dose-population histograms for deriving treatment margins in radiotherapy","volume":"47","author":"Van Herk","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.111351_b0015","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ijrobp.2007.04.065","article-title":"Feasibility of pathology-correlated lung imaging for accurate target definition of lung tumors","volume":"69","author":"Stroom","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.111351_b0020","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.ijrobp.2009.01.026","article-title":"Using histopathology breast cancer data to reduce clinical target volume margins at radiotherapy","volume":"74","author":"Stroom","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.111351_b0025","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.ijrobp.2010.09.038","article-title":"Evaluation of microscopic disease in oral tongue cancer using whole-mount histopathologic techniques: implications for the management of head-and-neck cancers","volume":"82","author":"Campbell","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.111351_b0030","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.ijrobp.2013.08.028","article-title":"Combined recipe for clinical target volume and planning target volume margins","volume":"88","author":"Stroom","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.111351_b0035","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1002\/1097-0142(20001015)89:8<1800::AID-CNCR21>3.0.CO;2-D","article-title":"Detailed mapping of prostate carcinoma foci: biopsy strategy implications","volume":"89","author":"Chen","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2025.111351_b0040","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0090-4295(02)01728-4","article-title":"Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens","volume":"60","author":"Wise","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.radonc.2025.111351_b0045","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1002\/cncr.22858","article-title":"Prostate cancer laterality as a rationale of focal ablative therapy for the treatment of clinically localized prostate cancer","volume":"110","author":"Mouraviev","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2025.111351_b0050","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.radonc.2015.01.021","article-title":"Gross tumor volume and clinical target volume in prostate cancer: how do satellites relate to the index lesion","volume":"115","author":"Hollmann","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.111351_b0055","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.radonc.2016.02.015","article-title":"Histopathology-derived modeling of prostate cancer tumor control probability: Implications for the dose to the tumor and the gland","volume":"119","author":"Ghobadi","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.111351_b0060","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/jmri.26933","article-title":"Histopathological features of MRI-invisible regions of prostate cancer lesions","volume":"51","author":"Van Houdt","year":"2020","journal-title":"J Magn Reson Imag"},{"key":"10.1016\/j.radonc.2025.111351_b0065","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.mri.2023.01.006","article-title":"Prostate cancer lesion detection, volume quantification and high-grade cancer differentiation using cancer risk maps derived from multiparametric MRI with histopathology as the reference standard","volume":"99","author":"Gibbons","year":"2023","journal-title":"Magn Reson Imag"},{"key":"10.1016\/j.radonc.2025.111351_b0070","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41585-020-00400-w","article-title":"Genomic and phenotypic heterogeneity in prostate cancer","volume":"18","author":"Haffner","year":"2020","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.radonc.2025.111351_b0075","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.media.2003.11.002","article-title":"Optimized prostate biopsy via a statistical atlas of cancer spatial distribution","author":"Shen","year":"2004","journal-title":"Med Image Anal"},{"key":"10.1016\/j.radonc.2025.111351_b0080","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.media.2009.05.002","article-title":"Sampling the spatial patterns of cancer: Optimized biopsy procedures for estimating prostate cancer volume and Gleason score","author":"Ou","year":"2009","journal-title":"Med Image Anal"},{"key":"10.1016\/j.radonc.2025.111351_b0085","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/mp.12086","article-title":"Multicenter validation of prosate tumor localization using multiparametric MRI and prior knowledge","volume":"44","author":"Dinh","year":"2017","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2025.111351_b0090","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.radonc.2016.07.018","article-title":"Image-guided radiotherapy for prostate cancer with cone-beam CT: dosimetric effects of imaging frequency and PTV margin","volume":"121","author":"Ariyaratne","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.111351_b0095","article-title":"Intrafraction motion and margin assessment for ethos online adaptive radiotherapy treatments of the prostate and seminal vesicles","volume":"9","author":"Byrne","year":"2023","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.111351_b0100","article-title":"Prostate motion in magnetic resonance imaging-guided radiotherapy and its impact on margins","author":"Kusters","year":"2025","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2025.111351_b0105","doi-asserted-by":"crossref","DOI":"10.1002\/acm2.13905","article-title":"Characterization of Ethos therapy systems for adaptive radiation therapy: a multi-machine comparison","volume":"24","author":"van de Schoot","year":"2023","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.radonc.2025.111351_b0110","doi-asserted-by":"crossref","DOI":"10.1002\/acm2.14111","article-title":"Characterization of mechanical and radiation isocenter on an MR-guided radiotherapy (MRgRT) Linac","volume":"24","author":"Bassiri","year":"2023","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.radonc.2025.111351_b0115","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/S0360-3016(01)01624-8","article-title":"A protocol for the reduction of systematic patient setup erros with minimal portal imaging workload","volume":"50","author":"De Boer","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.111351_b0120","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1088\/0031-9155\/52\/7\/013","article-title":"Convolution method and CTV-to-PTV margins for finite fractions and small systematic errors","volume":"52","author":"Gorden","year":"2007","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.radonc.2025.111351_b0125","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1088\/0031-9155\/58\/2\/319","article-title":"Calculating geometrical margins for hypofractionated radiotherapy","volume":"58","author":"Herschtal","year":"2013","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.radonc.2025.111351_b0130","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ijrobp.2014.09.025","article-title":"Need for consensus when prescribing stereotactic body radiation therapy for prostate cancer","volume":"91","author":"Eaton","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.111351_b0135","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/S0360-3016(01)02805-X","article-title":"Inclusion of geometric uncertainties in treatment plan evaluation","volume":"52","author":"Van Herk","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.111351_b0140","doi-asserted-by":"crossref","first-page":"7874","DOI":"10.1088\/1361-6560\/aa87fe","article-title":"Beyong the margin recipe: the probability of correct target dosage and tumor control in the presence of a dose limiting structure","volume":"62","author":"Witte","year":"2017","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.radonc.2025.111351_b0145","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.prro.2023.08.017","article-title":"Monitoring intrafraction motion of the prostate during radiation therapy: suggested practice points from a focused review","volume":"14","author":"Shimomura","year":"2024","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.111351_b0150","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20180948","article-title":"Comparison of prostate delineation on multimodality imaging for MR-guided radiotherapy","volume":"92","author":"Pathmanathan","year":"2019","journal-title":"Br J Radiol"},{"key":"10.1016\/j.radonc.2025.111351_b0155","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ijrobp.2016.04.018","article-title":"Toward prostate cancer contouring guidelines on magnetic resonance imaging: Dominant lesion gross and clinical target volume coverage via accurate histology fusion","volume":"96","author":"Gibson","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.111351_b0160","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/jmri.26933","article-title":"Histopathological features of MRI-invisible regions of prostate cancer lesions","volume":"51","author":"Van Houdt","year":"2020","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.radonc.2025.111351_b0165","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.596756","article-title":"Isotropic expansion of the intraprostatic gross tumor volume of primary prostate cancer patients defined in MRI \u2013 a correlation study with whole mount histopathological information as reference","volume":"10","author":"Kramer","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2025.111351_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.phro.2024.100633","article-title":"Histopathology-validated gross tumor volume delineations of intraprostatic lesions using PSMA-positron emission tomography\/multiparametric magnetic resonance imaging","author":"Grefve","year":"2024","journal-title":"Phys Imag Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.111351_b0175","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.radonc.2015.04.012","article-title":"Prostate tumor delineation using multiparametric magnetic resonance imaging: inter-observer variability and pathology validation","volume":"115","author":"Steenbergen","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.111351_b0180","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.radonc.2019.07.005","article-title":"[68Ga-]PSMA-11 PET\/CT and multiparametric MRI for gross tumor volume delineation in a slice by slice analysis with whole mount histopathology as a reference standard \u2013 Implications for focal radiotherapy planning in primary prostate cancer","volume":"141","author":"Bettermann","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.111351_b0185","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1200\/JCO-25-00274","article-title":"Focal boost to the intraprostatic tumor in external beam radiotherapy for patients with localized prostate cancer: 10-year outcomes of the FLAME trial","volume":"43","author":"Menne Guricov\u00e1","year":"2025","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2025.111351_b0190","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.radonc.2020.06.044","article-title":"Prostate intra-fraction motion during the preparation and delivery of MR-guided radiotherapy sessions on a 1.5T MR Linac","volume":"151","author":"De Muinck Keizer","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.111351_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109761","article-title":"Comparing adaptation strategies in MRI-guided online adaptive radiotherapy for prostate cancer: Implications for treatment margins","volume":"186","author":"Dassen","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.111351_b0200","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.radonc.2022.03.013","article-title":"Gating has a neglible impact on dose deliverd in MRI-guided online adaptive radiotherapy of prostate cancer","volume":"170","author":"Wahlstedt","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.111351_b0205","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.phro.2022.11.008","article-title":"A margin recipe for the management of intra-fraction target motion in radiotherapy","volume":"24","author":"Janssen","year":"2022","journal-title":"Phys Imag Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.111351_b0210","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.ijrobp.2023.12.035","article-title":"Quantifying intrafraction motion and the impact of gating for magnetic resonance imaging-guided stereotactic radiation therapy for prostate cancer: analysis of the magnetic resonance imaging arm from the MIRAGE phase 3 randomized trial","volume":"118","author":"Neylon","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.111351_b0215","article-title":"Investigating the use of comprehensive motion monitoring for intrafraction 3D drift assessment of hypofractionated prostate cancer patients on a 1.5T magnetic resonance imaging radiotherapy system","volume":"31","author":"Tsekas","year":"2024","journal-title":"Phys Imag Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.111351_b0220","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20201174","article-title":"Prostate cancer GTV delineation with biparametric MRI and 68Ga-PSMA-PET: comparison of expert contours and semi-automated models","volume":"94","author":"Hearn","year":"2021","journal-title":"Br J Radiol"},{"key":"10.1016\/j.radonc.2025.111351_b0230","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0090-4295(02)01728-4","article-title":"Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens","volume":"60","author":"Wise","year":"2002","journal-title":"Adult Urol"},{"key":"10.1016\/j.radonc.2025.111351_b0235","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/j.juro.2011.07.013","article-title":"Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds","volume":"186","author":"Turkbey","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.radonc.2025.111351_b0240","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.eururo.2014.08.079","article-title":"Multifocality and prostate cancer detection by multiparametric magnetic resonance imaging: correlation with whole-mount histopathology","volume":"67","author":"Le","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.radonc.2025.111351_b0245","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.radonc.2018.01.014","article-title":"ESTRO ACROP guideline on CT- and MRI-based target volume delineation for primary radiation therapy of localized prostate cancer","volume":"127","author":"Salembier","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.111351_b0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110535","article-title":"Intra-prostatic recurrences after radiotherapy with focal boost: location and dose mapping in the FLAME trial","author":"Menne Guricov\u00e1","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.111351_b0255","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/aacfb4","article-title":"The clinical target distribution: a probabilistic alternative to the clinical target volume","volume":"63","author":"Shusharina","year":"2018","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.radonc.2025.111351_b0260","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/ac1265","article-title":"Introducing a probabilistic definition of the target in a robust treatment planning framework","volume":"66","author":"Buti","year":"2021","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.radonc.2025.111351_b0265","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/ac2f8a","article-title":"Probabilistic target definition and planning in patients with prostate cancer","volume":"66","author":"Ferjan\u010di\u010d","year":"2021","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.radonc.2025.111351_b0270","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.3748\/wjg.v10.i20.2949","article-title":"Microscopic spread of low rectal cancer in regions of mesorectum: pathologic assessment with whole-mount sections","volume":"10","author":"Wang","year":"2004","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.radonc.2025.111351_b0275","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1200\/JCO.20.02873","article-title":"Focal boost to the intraprostatic tumor in external beam radiotherapy for patients with localized prostate cancer: results of the FLAME randomized phase III trial","volume":"39","author":"Kerkmeijer","year":"2021","journal-title":"J Clin Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025053551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025053551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T08:25:44Z","timestamp":1781511944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814025053551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":54,"alternative-id":["S0167814025053551"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2025.111351","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Are the CTV-to-PTV margins currently used in online adaptive radiotherapy for prostate cancer too large? The impact of the distribution of microscopic disease on treatment margin requirements","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2025.111351","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"111351"}}